Inactive Instrument
Tricida, Inc. Stock
Stocks
TCDA
US89610F1012
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -99.90% |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Alpern
BRD | Director/Board Member | 75 | 01/10/2013 |
| Director/Board Member | - | 09/01/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/11/22 | Sell | Director | 131,879 | 0.2369% | ||
| 22/11/22 | OrbiMed Advisors Private Equity
| Sell | Company | 10,280,947 | 18.4680% | |
| 22/11/22 | OrbiMed Advisors Private Equity
| Sell | Company | 10,280,947 | 18.4680% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -99.90% | -99.92% | - | - | 580 | |
| -1.23% | -1.91% | +0.98% | +17.94% | 50.47B | |
| -1.87% | -3.50% | +416.49% | +501.03% | 44.56B | |
| -1.09% | -0.48% | +40.96% | +16.34% | 43.08B | |
| -2.36% | -3.88% | +7.68% | +72.27% | 41.7B | |
| -0.94% | -1.77% | +18.34% | +46.84% | 33.21B | |
| -1.82% | -4.79% | +24.72% | +118.43% | 16.77B | |
| +7.01% | +4.98% | - | - | 16.28B | |
| +0.25% | -0.98% | +11.63% | +27.62% | 14.58B | |
| -1.39% | -3.78% | +78.16% | +38.90% | 13.92B | |
| Average | -10.30% | -1.24% | +74.87% | +104.92% | 30.51B | |
| Weighted average by Cap. | -0.89% | -1.05% | +88.95% | +121.70% |
Employees
57
